The over-50s, folks in care houses, and frontline well being and social care employees can be supplied a 3rd booster Covid-19 vaccine this winter, the Authorities has confirmed.
This comes after consultants from the Joint Committee on Vaccination and Immunisation (JCVI) delivered their recommendation on the booster to the Prime Minister Boris Johnson and Health Secretary Sajid Javid.
All those that are clinically extraordinarily weak and anybody aged 16 to 65 in an at-risk group group for Covid (who had been in precedence teams one to 9 throughout the preliminary vaccine rollout) may also be eligible for a jab.
Consultants stated the Pfizer/BioNTech vaccine ought to be the jab of alternative as a booster dose, and it will likely be given to round 30 million folks within the effected teams.
The JCVI has additionally stated it will likely be secure to manage the booster shot alongside the standard winter flu jab.
Three vaccines have been accredited as secure and efficient as boosters – AstraZeneca, Pfizer and Moderna – however consultants have determined to go for Pfizer as a desire, as proof exhibits it’s well-tolerated by recipients.
It may be given to folks even when they’ve beforehand obtained two doses of one of many different vaccines.
If crucial, Moderna could also be used as a substitute, however as a half-dose booster shot after research confirmed it was efficient with few side-effects.
Folks ought to obtain their third booster dose not less than six months after they obtained their second dose of a Covid vaccine.
When there’s extra information, consultants plan to have a look at whether or not boosters must also be supplied to wholesome folks underneath the age of fifty.
PM Boris Johnson is anticipated to offer a press convention this afternoon laying plans for holding Covid throughout the winter, whereas Health Secretary Javid is to offer an announcement on the subject to parliament.
Yesterday, England Chief Medical Officer Prof Chris Whitty appeared alongside colleagues from the opposite three residence nations to elucidate the choice to supply a single Covid vaccine to these aged between 12 and 15.